Therapeutic Drug Monitoring Market
Therapeutic Drug Monitoring Market By Product Type (Equipment, Consumables), By Technology (Immunoassays, Chromatography-Mass spectrometry), By Class of Drug (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs), By End User (Commercial/Private Labs, Hospital Labs, Other End Users) - Forecast Year 2024 – 2031
Healthcare // Medical Devices
The global therapeutic
drug monitoring market is foreseen to grow by 8.8%, from USD 15.75 Billion in
2021 to USD 3.42 Billion in 2029. Growing focus on R&D related to tdm, importance
of tdm in organ transplant procedures, increasing preference for precision
medicine is to drive the market for the upcoming forecast period. However, reluctance
of small hospitals to offer tdm services, requirement of high capital
investments remains one factor hindering the market growth over the anticipated
period.
Market Definition
What is Therapeutic drug
monitoring?
Market Overview
The
therapeutic drug monitoring market search study helps to thoroughly
understand the current trend in the market competitive analysis of the players
in the emerging market. Moreover, the DRO in the therapeutic drug monitoring
market offers valuable perspicuity and a current scenario for making the right
decision. The research study covers the eminent players in the market with a
detailed analysis of the company and a financial overview containing their net
sales, business mix and geographical reach It mainly focuses on the key
developments of the products/services offered by the company in recent years.
Besides, we at Zettabyte have the expertise to analyses the global therapeutic
drug monitoring market player's competitive landscape helping the client
comprehend their specific strategic growth approaches.
Therapeutic
drug monitoring market study by "Zettabyte Analytics" offers details
about the market scope, market segmentation, technological advancement in the therapeutic
drug monitoring market and highlights the optimistic, competitive landscape and
trends enduring over the years.
Major players in
the therapeutic drug monitoring market include Aalto Scientific, Ltd., Abbott,
Apdia Group, Ark Diagnostics, Inc., Biomérieux Sa, Bio-Rad Laboratories, Biotez
Berlin Buch Gmbh, Bühlmann Laboratories, Cambridge Life Sciences Limited,
Danaher Corporation, Diasystem Scandinavia Ab, Eagle Biosciences, Inc., Exagen
Inc., F. Hoffmann-La Roche, Grifols S.A., Hromsystems Instruments &
Chemicals Gmbh, Immundiagnostik Ag., Jasem Laboratory Systems And Solutions,
Randox Laboratories Ltd., R-Biopharm Ag, Sekisui Medical Co., Ltd., Siemens
Healthineers Ag, Theradiag Sa., Thermo Fisher Scientific, Utak.
COVID-19 Impact on Global Therapeutic
drug monitoring Market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. the impact of COVID-19 on the therapeutic drug
monitoring market has forced the companies to change their sourcing, pricing,
and promotion strategies. the therapeutic drug monitoring market players are
seen focusing more on optimizing the e-commerce networks with the rising
innovations in the digital sector, which are creating new business models for
the healthcare industry player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). the market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and therapeutic drug
monitoring market future markets are analyzed to understand their impact on demand
for the forecast period. growth rates have been estimated using correlation,
regression and time-series analysis.
Market Segmentation
For the purpose
of this report, the global therapeutic drug monitoring market segmented on the
basis of product type, technology, class of drug, end user, and region:
Product Type Outlook:
On the basis of
Product Type, the market is segmented into Equipment, Consumables. Further,
Equipment is segmented into Immunoassay Analyzers, Chromatography and MS
Detectors, Clinical Chemistry Analyzers.
Technology Outlook:
On the basis of
Technology, the market is segmented into Immunoassays, Chromatography-Mass
spectrometry. Further, Immunoassays is segmented into Radioimmunoassays,
Colorimetric Immunoassays, Other Immunoassays. Further, Chromatography-Mass
spectrometry is segmented into Liquid chromatography/mass spectrometry (LC-MS),
Gas Chromatography-Mass Spectrometry.
Figure 1 Therapeutic drug monitoring Market
By Technology (Market Size And Forecast By Value - USD Million, 2021 &
2029)
Class of Drug Outlook:
On the basis of
Class of Drug, the market is segmented into Antiepileptic Drugs, Antiarrhythmic
Drugs, Immunosuppressant Drugs, Antibiotic Drugs, Bronchodilator Drugs,
Psychoactive Drugs, Other drug classes.
End Use Outlook:
On the basis of
End User, the market is segmented into Commercial/Private Labs, Hospital Labs,
Other End Users.
Figure 2 End Use Outlook (Revenue, USD Million, 2021)
Regional Outlook (Revenue, USD million; 2021
& 2029)
|
Regional Outlook
(Revenue, USD million; 2018-2029) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 3 Therapeutic Drug Monitoring Market:
Regional Dynamics
An exclusive therapeutic
drug monitoring market research report provides an in-depth analysis of the
market dynamics across five regions: North America, Europe, South America,
Asia-Pacific, Middle East, and Africa. Furthermore, the market has been
evaluated by utilizing diverse research methodologies and internal statistical model.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2019-2021. some of the prominent players in the therapeutic
drug monitoring market include
· Aalto Scientific,
Ltd.
· Abbott
· Apdia Group
· Ark Diagnostics,
Inc.
· Biomérieux Sa
· Bio-Rad
Laboratories
· Biotez Berlin Buch
Gmbh
· Bühlmann
Laboratories
· Cambridge Life
Sciences Limited
· Danaher Corporation
· Diasystem
Scandinavia Ab
· Eagle Biosciences,
Inc.
· Exagen Inc.
· F. Hoffmann-La
Roche
· Grifols S.A.
· Hromsystems
Instruments & Chemicals Gmbh
· Immundiagnostik Ag.
· Jasem Laboratory
Systems And Solutions
· Randox Laboratories
Ltd.
· R-Biopharm Ag
· Sekisui Medical
Co., Ltd.
· Siemens
Healthineers Ag
· Theradiag Sa.
· Thermo Fisher
Scientific
· Utak
Global Therapeutic drug monitoring market Report
Scope
|
Historical
data |
2018 - 2020 |
|
Base
year for estimation |
2021 |
|
Forecast
period |
2022 - 2029 |
|
Market
size value in 2022 |
USD XX Billion |
|
Revenue
forecast in 2029 |
USD 3.42 Billion |
|
Growth
Rate |
CAGR of 8.8%
from 2022 to 2029 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2022 to 2029 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Product Type, Technology, Class of Drug,
End User |
|
Key
companies profiled |
Abbott, Thermo
Fisher Scientific, F. Hoffmann-La Roche |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Product Type Outlook (Revenue, USD Million/Billion;
2018-2029)
· Equipment
o Immunoassay
Analyzers
o Chromatography and
MS Detectors
o Clinical Chemistry
Analyzers
· Consumables
Technology Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Immunoassays
o Radioimmunoassays
o Colorimetric
Immunoassays
o Other Immunoassays
· Chromatography-Mass
spectrometry
o Chromatography-Mass
spectrometry
o Liquid
chromatography/mass spectrometry (LC-MS)
o Gas Chromatography-Mass
Spectrometry
Class of Drug Outlook (Revenue, USD Million/Billion;
2018-2029)
· Antiepileptic Drugs
· Antiarrhythmic
Drugs
· Immunosuppressant
Drugs
· Antibiotic Drugs
· Bronchodilator
Drugs
· Psychoactive Drugs
· Other drug classes
End User Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Commercial/Private
Labs
· Hospital Labs
· Other End Users
Regional Outlook (Revenue, USD
Million/Billion; 2018-2029)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
Reasons to Buy the Report:
· Save and reduce
time carrying out entry-level research by identifying the growth, size, leading
players and segments in the global therapeutic drug monitoring market
· Highlights key
business priorities in order to guide the companies to reform their business strategies
and establish themselves in the wide geography.
· The key findings
and recommendations highlight crucial progressive industry trends in the therapeutic
drug monitoring market, thereby allowing players to develop effective long-term
strategies in order to garner their market revenue.
· Develop/modify
business expansion plans by using substantial growth offering developed and
emerging markets.
· Scrutinize in-depth
global market trends and outlook coupled with the factors driving the market,
as well as those restraining the growth at a certain extent.
· Enhance the
decision-making Class of Drug by understanding the strategies that underpin
commercial interest with respect to products, segmentation and industry
verticals.
TOC
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States